Loading…
Chinese amino acid suppliers are shifting from bulk production toward higher-value valine, isoleucine and glutamine for supplements and health products. CCM, a market intelligence firm, warns of mislabelling, underdosed products and illegal additive use in the sector.
A shift away from bulk amino acid output could tighten feed-grade supply over time, though the article's main concern is product quality rather than an immediate price move.
nutraingredients.comGary ScattergoodMar 21, 2018Not enough comparable past events yet for a historical read.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
